Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer
by
Geyer, Charles E
, Fleming, Gini F
, Coates, Alan S
, Climent, Miguel A
, Coleman, Robert
, Debled, Marc
, Buchholz, Stefan
, Pavesi, Lorenzo
, Ruhstaller, Thomas
, Stearns, Vered
, Láng, István
, Di Leo, Angelo
, Puglisi, Fabio
, Spazzapan, Simon
, Colleoni, Marco
, Francis, Prudence A
, Burstein, Harold J
, Gómez, Henry L
, Bonnefoi, Hervé R
, Tondini, Carlo
, Maibach, Rudolf
, Goldhirsch, Aron
, Davidson, Nancy E
, Rabaglio-Poretti, Manuela
, Regan, Meredith M
, Ingle, James N
, Bellet, Meritxell
, Goetz, Matthew P
, Martino, Silvana
, Pinotti, Graziella
, Ciruelos, Eva
, Winer, Eric P
, Gelber, Richard D
, Ruepp, Barbara
, Walley, Barbara A
, Pagani, Olivia
in
Adjuvants
/ Adult
/ Androstadienes - adverse effects
/ Androstadienes - therapeutic use
/ Antineoplastic Agents, Hormonal - adverse effects
/ Antineoplastic Agents, Hormonal - therapeutic use
/ Aromatase
/ Aromatase Inhibitors - adverse effects
/ Aromatase Inhibitors - therapeutic use
/ Breast cancer
/ Breast Neoplasms - drug therapy
/ Breast Neoplasms - surgery
/ Cancer therapies
/ Chemotherapy
/ Chemotherapy, Adjuvant
/ Design
/ Disease-Free Survival
/ Drug dosages
/ Endocrine therapy
/ ErbB-2 protein
/ Female
/ Follow-Up Studies
/ Hospitals
/ Humans
/ Kaplan-Meier Estimate
/ Medical research
/ Middle Aged
/ Neoplasm Recurrence, Local - prevention & control
/ Oncology
/ Premenopause
/ Receptor, ErbB-2
/ Survival
/ Tamoxifen
/ Tamoxifen - adverse effects
/ Tamoxifen - therapeutic use
/ Womens health
/ Young Adult
2018
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer
by
Geyer, Charles E
, Fleming, Gini F
, Coates, Alan S
, Climent, Miguel A
, Coleman, Robert
, Debled, Marc
, Buchholz, Stefan
, Pavesi, Lorenzo
, Ruhstaller, Thomas
, Stearns, Vered
, Láng, István
, Di Leo, Angelo
, Puglisi, Fabio
, Spazzapan, Simon
, Colleoni, Marco
, Francis, Prudence A
, Burstein, Harold J
, Gómez, Henry L
, Bonnefoi, Hervé R
, Tondini, Carlo
, Maibach, Rudolf
, Goldhirsch, Aron
, Davidson, Nancy E
, Rabaglio-Poretti, Manuela
, Regan, Meredith M
, Ingle, James N
, Bellet, Meritxell
, Goetz, Matthew P
, Martino, Silvana
, Pinotti, Graziella
, Ciruelos, Eva
, Winer, Eric P
, Gelber, Richard D
, Ruepp, Barbara
, Walley, Barbara A
, Pagani, Olivia
in
Adjuvants
/ Adult
/ Androstadienes - adverse effects
/ Androstadienes - therapeutic use
/ Antineoplastic Agents, Hormonal - adverse effects
/ Antineoplastic Agents, Hormonal - therapeutic use
/ Aromatase
/ Aromatase Inhibitors - adverse effects
/ Aromatase Inhibitors - therapeutic use
/ Breast cancer
/ Breast Neoplasms - drug therapy
/ Breast Neoplasms - surgery
/ Cancer therapies
/ Chemotherapy
/ Chemotherapy, Adjuvant
/ Design
/ Disease-Free Survival
/ Drug dosages
/ Endocrine therapy
/ ErbB-2 protein
/ Female
/ Follow-Up Studies
/ Hospitals
/ Humans
/ Kaplan-Meier Estimate
/ Medical research
/ Middle Aged
/ Neoplasm Recurrence, Local - prevention & control
/ Oncology
/ Premenopause
/ Receptor, ErbB-2
/ Survival
/ Tamoxifen
/ Tamoxifen - adverse effects
/ Tamoxifen - therapeutic use
/ Womens health
/ Young Adult
2018
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer
by
Geyer, Charles E
, Fleming, Gini F
, Coates, Alan S
, Climent, Miguel A
, Coleman, Robert
, Debled, Marc
, Buchholz, Stefan
, Pavesi, Lorenzo
, Ruhstaller, Thomas
, Stearns, Vered
, Láng, István
, Di Leo, Angelo
, Puglisi, Fabio
, Spazzapan, Simon
, Colleoni, Marco
, Francis, Prudence A
, Burstein, Harold J
, Gómez, Henry L
, Bonnefoi, Hervé R
, Tondini, Carlo
, Maibach, Rudolf
, Goldhirsch, Aron
, Davidson, Nancy E
, Rabaglio-Poretti, Manuela
, Regan, Meredith M
, Ingle, James N
, Bellet, Meritxell
, Goetz, Matthew P
, Martino, Silvana
, Pinotti, Graziella
, Ciruelos, Eva
, Winer, Eric P
, Gelber, Richard D
, Ruepp, Barbara
, Walley, Barbara A
, Pagani, Olivia
in
Adjuvants
/ Adult
/ Androstadienes - adverse effects
/ Androstadienes - therapeutic use
/ Antineoplastic Agents, Hormonal - adverse effects
/ Antineoplastic Agents, Hormonal - therapeutic use
/ Aromatase
/ Aromatase Inhibitors - adverse effects
/ Aromatase Inhibitors - therapeutic use
/ Breast cancer
/ Breast Neoplasms - drug therapy
/ Breast Neoplasms - surgery
/ Cancer therapies
/ Chemotherapy
/ Chemotherapy, Adjuvant
/ Design
/ Disease-Free Survival
/ Drug dosages
/ Endocrine therapy
/ ErbB-2 protein
/ Female
/ Follow-Up Studies
/ Hospitals
/ Humans
/ Kaplan-Meier Estimate
/ Medical research
/ Middle Aged
/ Neoplasm Recurrence, Local - prevention & control
/ Oncology
/ Premenopause
/ Receptor, ErbB-2
/ Survival
/ Tamoxifen
/ Tamoxifen - adverse effects
/ Tamoxifen - therapeutic use
/ Womens health
/ Young Adult
2018
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer
Journal Article
Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer
2018
Request Book From Autostore
and Choose the Collection Method
Overview
At 8 years of follow-up, premenopausal women with breast cancer had higher rates of disease-free and overall survival with the addition of ovarian suppression to antiestrogen therapy and a higher rate of hormonal side effects than with tamoxifen alone.
Publisher
Massachusetts Medical Society
Subject
/ Adult
/ Androstadienes - adverse effects
/ Androstadienes - therapeutic use
/ Antineoplastic Agents, Hormonal - adverse effects
/ Antineoplastic Agents, Hormonal - therapeutic use
/ Aromatase Inhibitors - adverse effects
/ Aromatase Inhibitors - therapeutic use
/ Breast Neoplasms - drug therapy
/ Design
/ Female
/ Humans
/ Neoplasm Recurrence, Local - prevention & control
/ Oncology
/ Survival
This website uses cookies to ensure you get the best experience on our website.